JPOST Repositoryapplication/xmlhttps://storage.jpostdb.org/JPST003824/files/20240808_kitamura_HeLa_240611_SP_MetDB_TMTpro_FAIMS_05-07.xlsxhttps://storage.jpostdb.org/JPST003824/files/20241003_hiroki_GB2_240611_SP_MetDB_TMTpro_FAIMS_05-07.xlsxhttps://storage.jpostdb.org/JPST003824/files/20241003_hiroki_GB2_240611_SP_MetDB_TMTpro_FAIMS_07.rawhttps://storage.jpostdb.org/JPST003824/files/20241003_hiroki_GB2_240611_SP_MetDB_TMTpro_FAIMS_05.rawhttps://storage.jpostdb.org/JPST003824/files/20240808_kitamura_HeLa_240611_SP_MetDB_TMTpro_FAIMS_07.rawhttps://storage.jpostdb.org/JPST003824/files/20240808_kitamura_HeLa_240611_SP_MetDB_TMTpro_FAIMS_05.rawprimaryOK200ProteomicsMasaaki OyamaHomo Sapiens (human)https://repository.jpostdb.org/entry/JPST003824The Institute of Medical Science, The University of TokyojPOSTfalseTMT-based quantitative proteomic analysis of EGF-treated human cancer cellsWe performed a TMT-based quantitative proteomic analysis of EGF-treated human cancer cells in the presence/absence of Torin 1 using advanced RTS platform on Orbitrap Eclipse Tribrid MS system.Sun May 17 00:00:00 BST 2026PXD0641889606